PFE: A Frozen Dividend and a 15-Year Streak on the Clock
Pfizer has maintained its quarterly dividend at $0.43 for seven consecutive quarters, signaling a stagnation in growth that income investors should note. With a critical decision looming in December 2026 regarding future payouts, the current freeze may indicate a shift in its 15-year growth streak. In contrast, competitors GSK...
Read More >
